Bernard Courtieu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bernard courtieu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bernard Courtieu Today - Breaking & Trending Today

IntegraGen: Annual Results 2023 - Positive EBITDA Reflecting Tight Cost Control

Increase in services provided in 2023 by all sequencing platforms, excluding COVID-related activities

Positive EBITDA for the third year running, despite inflation impacting reagent. ....

France General , United States , United Kingdom , Institut Pasteur , Bernard Courtieu , College Of American Pathologists , Clinical Laboratory Improvement Amendments , Regulatory News , American Pathologists , Mutualized Microbiology Platform , Quality Assurance , State Guaranteed Loan , Euronext Growth ,

IntegraGen Reports €11.8M Revenues for 2023

IntegraGen Reports €11.8M Revenues for 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France General , United Kingdom , United States , Virginie Decoster , Institut Pasteur , Bernard Courtieu , Oncodna Group , College Of American Pathologists , American Pathologists , Euronext Growth ,

IntegraGen Reports €5.6m in Revenues for H1 2023 Representing 13% Decrease Compared to H1 2022 and a Cash Position of €4.3m

IntegraGen Reports €5.6m in Revenues for H1 2023 Representing 13% Decrease Compared to H1 2022 and a Cash Position of €4.3m
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United Kingdom , France General , Bernard Courtieu , Belgian Oncodna Group , Oncodna Group , Euronext Growth , Die Experten ,

IntegraGen : reports 2022 annual results with a growth of 16% in revenues and a positive EBITDA.

Increase of activities performed on all sequencing platforms

Positive EBITDA for the second consecutive year despite inflation impact on reagents

. | April 24, 2023 ....

United Kingdom , France General , Institut Pasteur , Gustave Roussy , Institut Curie , Bernard Courtieu , European Society Of Medical Oncology , Oncodna Group , European Society , Medical Oncology , Assistance Publique H , Euronext Growth , Integragen Stock Exchange , Press Release , N Alint Fr0010908723 ,

IntegraGen Reports €12.6m in Revenues for 2022 Representing 16% Growth Compared to 2021 and a Cash Position of €4.5m

Growth supported by the high-throughput genomic sequencing laboratory in Evry Continued sequencing activities on platforms operated on behalf of third parties supported by new clinical research ....

France General , United Kingdom , Bernard Courtieu , Oncodna Group , Euronext Growth , Media Relations ,